Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden ...
It’s not a new question, but it is one that is gaining increased traction: Is there a link between Novo Nordisk’s diabetes ...
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated ...
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...
A Danish-Norwegian cohort study on the use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy, or NAION, a rare condition that causes sudden vision loss in one eye due ...